198 related articles for article (PubMed ID: 17948978)
1. Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.
Cole DC; Stock JR; Lennox WJ; Bernotas RC; Ellingboe JW; Boikess S; Coupet J; Smith DL; Leung L; Zhang GM; Feng X; Kelly MF; Galante R; Huang P; Dawson LA; Marquis K; Rosenzweig-Lipson S; Beyer CE; Schechter LE
J Med Chem; 2007 Nov; 50(23):5535-8. PubMed ID: 17948978
[TBL] [Abstract][Full Text] [Related]
2. Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists.
Bernotas RC; Lenicek S; Antane S; Cole DC; Harrison BL; Robichaud AJ; Zhang GM; Smith D; Platt B; Lin Q; Li P; Coupet J; Rosenzweig-Lipson S; Beyer CE; Schechter LE
Bioorg Med Chem; 2009 Jul; 17(14):5153-63. PubMed ID: 19523834
[TBL] [Abstract][Full Text] [Related]
3. Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.
Cole DC; Lennox WJ; Stock JR; Ellingboe JW; Mazandarani H; Smith DL; Zhang G; Tawa GJ; Schechter LE
Bioorg Med Chem Lett; 2005 Nov; 15(21):4780-5. PubMed ID: 16125933
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
[TBL] [Abstract][Full Text] [Related]
5. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
Choi SK; Green D; Ho A; Klein U; Marquess D; Taylor R; Turner SD
J Med Chem; 2008 Jun; 51(12):3609-16. PubMed ID: 18507369
[TBL] [Abstract][Full Text] [Related]
6. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.
Riemer C; Borroni E; Levet-Trafit B; Martin JR; Poli S; Porter RH; Bös M
J Med Chem; 2003 Mar; 46(7):1273-6. PubMed ID: 12646038
[TBL] [Abstract][Full Text] [Related]
7. Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.
Nirogi R; Dwarampudi A; Kambhampati R; Bhatta V; Kota L; Shinde A; Badange R; Jayarajan P; Bhyrapuneni G; Dubey PK
Bioorg Med Chem Lett; 2011 Aug; 21(15):4577-80. PubMed ID: 21724392
[TBL] [Abstract][Full Text] [Related]
8. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists.
Bolli MH; Abele S; Binkert C; Bravo R; Buchmann S; Bur D; Gatfield J; Hess P; Kohl C; Mangold C; Mathys B; Menyhart K; Müller C; Nayler O; Scherz M; Schmidt G; Sippel V; Steiner B; Strasser D; Treiber A; Weller T
J Med Chem; 2010 May; 53(10):4198-211. PubMed ID: 20446681
[TBL] [Abstract][Full Text] [Related]
9. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.
Schechter LE; Lin Q; Smith DL; Zhang G; Shan Q; Platt B; Brandt MR; Dawson LA; Cole D; Bernotas R; Robichaud A; Rosenzweig-Lipson S; Beyer CE
Neuropsychopharmacology; 2008 May; 33(6):1323-35. PubMed ID: 17625499
[TBL] [Abstract][Full Text] [Related]
10. N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist.
Xu YC; Schaus JM; Walker C; Krushinski J; Adham N; Zgombick JM; Liang SX; Kohlman DT; Audia JE
J Med Chem; 1999 Feb; 42(3):526-31. PubMed ID: 9986723
[TBL] [Abstract][Full Text] [Related]
11. Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.
Cheng Y; Albrecht BK; Brown J; Buchanan JL; Buckner WH; DiMauro EF; Emkey R; Fremeau RT; Harmange JC; Hoffman BJ; Huang L; Huang M; Lee JH; Lin FF; Martin MW; Nguyen HQ; Patel VF; Tomlinson SA; White RD; Xia X; Hitchcock SA
J Med Chem; 2008 Aug; 51(16):5019-34. PubMed ID: 18680277
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
[TBL] [Abstract][Full Text] [Related]
13. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists.
Holmberg P; Sohn D; Leideborg R; Caldirola P; Zlatoidsky P; Hanson S; Mohell N; Rosqvist S; Nordvall G; Johansson AM; Johansson R
J Med Chem; 2004 Jul; 47(16):3927-30. PubMed ID: 15267230
[TBL] [Abstract][Full Text] [Related]
14. 8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands.
Heightman TD; Gaster LM; Pardoe SL; Pilleux JP; Hadley MS; Middlemiss DN; Price GW; Roberts C; Scott CM; Watson JM; Gordon LJ; Holland VA; Powles J; Riley GJ; Stean TO; Trail BK; Upton N; Austin NE; Ayrton AD; Coleman T; Cutler L
Bioorg Med Chem Lett; 2005 Oct; 15(19):4370-4. PubMed ID: 16039851
[TBL] [Abstract][Full Text] [Related]
15. Indene-based scaffolds. 2. An indole-indene switch: discovery of novel indenylsulfonamides as 5-HT6 serotonin receptor agonists.
Alcalde E; Mesquida N; López-Pérez S; Frigola J; Mercè R
J Med Chem; 2009 Feb; 52(3):675-87. PubMed ID: 19159187
[TBL] [Abstract][Full Text] [Related]
16. 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.
Mattsson C; Sonesson C; Sandahl A; Greiner HE; Gassen M; Plaschke J; Leibrock J; Böttcher H
Bioorg Med Chem Lett; 2005 Oct; 15(19):4230-4. PubMed ID: 16055331
[TBL] [Abstract][Full Text] [Related]
17. A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.
May JA; Chen HH; Rusinko A; Lynch VM; Sharif NA; McLaughlin MA
J Med Chem; 2003 Sep; 46(19):4188-95. PubMed ID: 12954071
[TBL] [Abstract][Full Text] [Related]
18. Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships.
Klein MT; Dukat M; Glennon RA; Teitler M
J Pharmacol Exp Ther; 2011 Jun; 337(3):860-7. PubMed ID: 21422162
[TBL] [Abstract][Full Text] [Related]
19. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
Holenz J; Mercè R; Díaz JL; Guitart X; Codony X; Dordal A; Romero G; Torrens A; Mas J; Andaluz B; Hernández S; Monroy X; Sánchez E; Hernández E; Pérez R; Cubí R; Sanfeliu O; Buschmann H
J Med Chem; 2005 Mar; 48(6):1781-95. PubMed ID: 15771424
[TBL] [Abstract][Full Text] [Related]
20. N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands.
Liu Z; Chen X; Sun P; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2008 Sep; 16(18):8335-8. PubMed ID: 18783955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
